Mutations

PSEN1 E120D (A>T)

Overview

Pathogenicity: Alzheimer's Disease : Pathogenic
Clinical Phenotype: Alzheimer's Disease
Reference Assembly: GRCh37 (105)
Position: Chr14:73640295 A>T
dbSNP ID: rs63751272
Coding/Non-Coding: Coding
Mutation Type: Point, Missense
Codon Change: GAA to GAT
Reference Isoform: PSEN1 isoform 1 (467 aa)
Genomic Region: Exon 5

Findings

This mutation was first identified in two Israeli siblings with a family history of early onset Alzheimer’s disease accompanied by seizures. The reported pedigree included four affected individuals over three generations. The proband experienced onset of progressive memory impairment and disorientation at age 48. His father died at age 55 with similar symptoms. The proband’s two siblings, a sister and a brother, experienced progressive cognitive dysfunction at ages 43 and 46 years respectively, and developed epileptic seizures within 18 months of symptom onset (Reznik-Wolf et al., 1996).

In a paper investigating patterns of pathology associated with various familial AD mutations, two brain specimens from patients carrying E120D mutations were analyzed, but it was not indicated whether these individuals carried the A>T or A>C transversion. Age of onset in these individuals was recorded as 34 and 53 and age at death as 51 and 62 years, respectively. Language loss, seizures, and rigidity were noted as clinical features (Mann et al., 2001).

Neuropathology

Unknown.

Biological Effect

An in vitro assay using purified proteins to test the ability of an E120D mutant (nucleotide change unspecified) to cleave the APP-C99 substrate revealed decreased Aβ42, and particularly Aβ40, production resulting in a greater than 5-fold increase in the Aβ42/Aβ40 ratio (Sun et al., 2017).

Last Updated: 15 Sep 2019

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

References

Paper Citations

  1. . A novel mutation of presenilin 1 in familial Alzheimer's disease in Israel detected by denaturing gradient gel electrophoresis. Hum Genet. 1996 Dec;98(6):700-2. PubMed.
  2. . Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease. Am J Pathol. 2001 Jun;158(6):2165-75. PubMed.
  3. . Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase. Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E476-E485. Epub 2016 Dec 5 PubMed.

Further Reading

No Available Further Reading

Protein Diagram

Primary Papers

  1. . A novel mutation of presenilin 1 in familial Alzheimer's disease in Israel detected by denaturing gradient gel electrophoresis. Hum Genet. 1996 Dec;98(6):700-2. PubMed.

Other mutations at this position

Alzpedia

Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.